FDA•MODERATE
Bisoprolol Fumarate and Hydrochlorothiazide Tablets 2.5 mg/6.25 mg
Unichem Pharmaceuticals recalls Bisoprolol/Hydrochlorothiazide 2.5/6.25 mg tablets (NDC 29300-187-01) due to N-Nitroso Bisoprolol impurity specification failure.
Filters
Category
Agency
Severity
Date
Distributed in
Drugs Recalls
Back to home ←
FDA•MODERATEMethylprednisolone Tablets USP Dosepak 4 mgGreenstone is recalling methylprednisolone 4 mg tablets (NDC 59762-4440-2) due to incorrect blister foil orientation causing incorrect dosing information.
FDA•MODERATEFurosemide Tablets USP 40 mgRising Pharmaceuticals is recalling Furosemide Tablets 40 mg (NDC 64980-563-10) due to foreign substance contamination.
FDA•MODERATEThyroid, USPSpecialty Process Labs is recalling Thyroid, USP (NDC 81305-100-02) due to subpotency.
FDA•MODERATELanreotide Injection 120 mg/0.5 mLCipla is recalling Lanreotide Injection 120 mg/0.5 mL due to the presence of particulate matter.
FDA•MODERATEAQ 120 GFEW Aquarion Preserved CartridgesEncon Safety Products is recalling AQ 120 GFEW Aquarion Preserved Cartridges due to cGMP manufacturing deviations.